# EDGAR Filing Document

**Accession Number:** 0001871181
**File Stem:** 0001493152-23-000570
**Filing Date:** 2023-1
**Character Count:** 4612
**Document Hash:** 387a10bac89e233c2778c1680caab8c0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-000570.hdr.sgml**: 20230105

**ACCESSION NUMBER**: 0001493152-23-000570

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20221230

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230105

**DATE AS OF CHANGE**: 20230105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Qualis Innovations, Inc.
- **CENTRAL INDEX KEY:** 0001871181
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 842488498
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-260982
- **FILM NUMBER:** 23510965

**BUSINESS ADDRESS:**
- **STREET 1:** 225 WILMINGTON WEST CHESTER PIKE,
- **STREET 2:** SUITE 202
- **CITY:** CHADDS FORD
- **STATE:** PA
- **ZIP:** 19317
- **BUSINESS PHONE:** 610-620-3753

**MAIL ADDRESS:**
- **STREET 1:** 225 WILMINGTON WEST CHESTER PIKE,
- **STREET 2:** SUITE 202
- **CITY:** CHADDS FORD
- **STATE:** PA
- **ZIP:** 19317

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): December 30, 2022

**<u>QUALIS INNOVATIONS, INC.</u>**

(Exact name of registrant as specified in its charter)

Nevada 333-260982 84-2488498 <br> (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

**225 Wilmington West Chester Pike**

**Suite 200 # 145**

**Chadds Ford** **, Pennsylvania 19317**

(Address of principal executive offices)

Registrant's telephone number, including area code: **<u>Telephone: : (484) 483-2134</u>**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| There were 8,475,950 shares of common stock $0.001 par value, issued and outstanding as of November 14, 2022 | QLIS | OTC Pink marketplace |

---

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On December 30, 2022, Dr. Joseph V. Pergolizzi, Jr., a member of, and Chairman of, the Board of Directors of Qualis Innovations, Inc. (the "<u>Company</u>") and the acting Chief Executive Officer of the Company, notified the Company of his decision to resign, effective immediately, from his position as a member of, and Chairman of, the Board of Directors of the Company and from any and all offices he may hold with the Company, including as acting Chief Executive Officer of the Company. Dr. Pergolizzi's resignation was to pursue other business opportunities and did not result from any disagreement with the Company, the Company's Board of Directors, or the Company's management on any matter relating to the Company's operations, policies or practices.

---

| | |
|:---|:---|
| **Exhibit No** | **Description** |
| 1 | [Formal resignation letter for Joseph Pergolizzi as CEO of Qualis and its subsidiaries, submitted to the Qualis Board of Directors on December 30, 2022.](ex1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **QUALIS INNOVATIONS, INC.** |
| Date: | December 30, 2022 |  |
|  | | */s/ John Ballard* |
|  |  | John Ballard, Chief Financial Officer |

---

## Ex-1

**Exhibit 1**

![](ex-1_001.jpg)